Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Opgen Inc (NQ: OPGN )

2.320 USD -0.050 (-2.11%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Opgen Inc

< Previous 1 2 3 4 Next >
Thinking about buying stock in Ocugen, Rapt Therapeutics, ContextLogic, OpGen, or Clean Energy Fuels?
InvestorsObserver issues critical PriceWatch Alerts for OCGN, RAPT, WISH, OPGN, and CLNE. 
From PR Newswire
OpGen Announces Partial Adjournment of Annual Meeting for Proposal 2 with All Other Proposals Passed
From GlobeNewswire News Releases
OpGen Group Company Ares Genetics Presents at AWS and Twist Bioscience Webinars
From GlobeNewswire News Releases
OpGen Submits Updated 510(k) Summary to FDA and Successfully Completes Move to New Headquarters in Maryland
From GlobeNewswire News Releases
OpGen Reports First Quarter 2021 Financial Results and Provides Business Update
From GlobeNewswire News Releases
OpGen to Provide Business Update and Financial Results for the First Quarter 2021 on May 13th at 8:30 a.m. Eastern Time
From GlobeNewswire News Releases
OpGen Extends and Expands Partnership with New York State Department of Health to Detect Antimicrobial-Resistant Infections
From GlobeNewswire News Releases
OpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in COVID-19 Patients
From GlobeNewswire News Releases
OpGen Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2020
From GlobeNewswire News Releases
Thinking about buying stock in OpGen, GameStop, Johnson & Johnson, BioNano Genomics, or SINTX Technologies?
InvestorsObserver issues critical PriceWatch Alerts for OPGN, GME, JNJ, BNGO, and SINT. 
From PR Newswire
Thinking about buying stock in Inovalon Holdings, OpGen, Shift Technologies, Surface Oncology, or Aytu Bioscience?
InvestorsObserver issues critical PriceWatch Alerts for INOV, OPGN, SFT, SURF, and AYTU. 
From PR Newswire
Thinking about buying stock in OpGen, XpresSpa, Jaguar Health, Orchard Therapeutics, or Novan?
InvestorsObserver issues critical PriceWatch Alerts for OPGN, XSPA, JAGX, ORTX, and NOVN. 
From PR Newswire
OpGen Announces Publication of Final Study Results of Unyvero HPN Panel for Diagnosis of Bacterial Co-Infections in ICU Patients with COVID-19 Pneumonia
From GlobeNewswire News Releases
Thinking about buying stock in Aslan Pharmaceuticals, electroCore, Novan, OpGen, or Salarius Pharmaceuticals?
InvestorsObserver issues critical PriceWatch Alerts for ASLN, ECOR, NOVN, OPGN, and SLRX. 
From PR Newswire
OpGen Wins Chinese NMPA Approval for the Curetis Unyvero System
From GlobeNewswire News Releases
OpGen Subsidiary Ares Genetics Announces Publication of Study Introducing Best Practice Techniques for AI-powered Prediction of Antibiotic Susceptibility Testing by Next-Generation Sequencing
From GlobeNewswire News Releases
OpGen, Inc. Announces $25 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules
From GlobeNewswire News Releases
OpGen Announces Preliminary Unaudited Revenue for Fiscal 2020 and Provides Business Update
From GlobeNewswire News Releases
OpGen Subsidiary Curetis and Annar Enter into Unyvero Distribution Partnership for Colombia
From GlobeNewswire News Releases
Results from 1,400 Patient Sample Multicenter Study Published: Unyvero LRT BAL Panel Provides Accurate Detection in Bronchoalveolar Lavage Fluid, Allowing Enhanced Diagnosis of Lower Respiratory Tract
From GlobeNewswire News Releases
OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics
From GlobeNewswire News Releases
OpGen Group Company Ares Genetics Advances ares-genetics.cloud Platform, Presents Update at Scientific Conferences, Expects Granting of Key Patent
From GlobeNewswire News Releases
OpGen, Inc. Announces $10 Million Private Placement Priced at the Market
From GlobeNewswire News Releases
OpGen Group Company Ares Genetics Commercially Launches NGS-based Antibiotic Resistance Testing Service for Native Specimens and Receives Bulk Order from Public Health Agency
From GlobeNewswire News Releases
OpGen Reports Third Quarter 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
OpGen to Provide Business Update and Financial Results for the Third Quarter 2020
From GlobeNewswire News Releases
OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators
From GlobeNewswire News Releases
OpGen Provides Business and Pipeline Update and Announces Preliminary Unaudited Revenue and Cash Position for the Third Quarter 2020
From GlobeNewswire News Releases
OpGen Issues Formal Response to FDA’s Requests for Additional Information and Expects Near Term FDA Clearance Decision for Acuitas AMR Gene Panel
From GlobeNewswire News Releases
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.